Blinatumomab, Methotrexate, Cytarabine, and Ponatinib Trial
Phase 2
90
about 10 years
18+
1 site in TX
What this study is about
This trial is testing how well blinatumomab, methotrexate, cytarabine, and ponatinib work in treating patients with Philadelphia chromosome-positive or BCR-ABL positive acute lymphoblastic leukemia that has returned or not responded to treatment. This treatment involves a combination of immunotherapy and chemotherapy drugs.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Blinatumomab
- 2.Take Cytarabine
- 3.Take Methotrexate
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
blinatumomab, cytarabine, methotrexate, ponatinib
injection, intravenous, injection (Injection), oral (Oral Tablet)
Primary: Event-free survival, Overall response rate (ORR) in relapsed/refractory ALL, Overall survival, Relapse-free survival
Oncology